BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36297038)

  • 21. The Brown Algae
    Kim M; Park M
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathways.
    Sun Y; Liu Y; He W; Wang C; Tickner J; Kuek V; Zhou C; Wang H; Zou X; Hong Z; Yang F; Shao M; Chen L; Xu J
    J Cell Physiol; 2019 Jul; 234(7):11792-11804. PubMed ID: 30515822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
    Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
    BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts.
    Lee SK; Kim H; Park J; Kim HJ; Kim KR; Son SH; Park KK; Chung WY
    Sci Rep; 2017 Dec; 7(1):17332. PubMed ID: 29230013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Osteoporotic Effects of
    Lim HJ; Park EJ; Won YS; Bak SG; Cheong SH; Lee SW; Lee S; Lee SJ; Rho MC
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osthole-loaded N-octyl-O-sulfonyl chitosan micelles (NSC-OST) inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in rats.
    Wang L; Zheng S; Huang G; Sun J; Pan Y; Si Y; Tu P; Xu G; Ma Y; Guo Y
    J Cell Mol Med; 2020 Apr; 24(7):4105-4117. PubMed ID: 32126148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.
    Wang Y; Li X; Zhou S; Li J; Zhu Y; Wang Q; Zhao F
    Oxid Med Cell Longev; 2022; 2022():7727006. PubMed ID: 36148414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule inhibitor RepSox prevented ovariectomy-induced osteoporosis by suppressing osteoclast differentiation and bone resorption.
    Mei L; Sang W; Chen Z; Zheng L; Jin K; Lou C; Huang W; He D
    J Cell Physiol; 2018 Dec; 233(12):9724-9738. PubMed ID: 30059597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of pharmacodynamics and metabolomics reveals the therapeutic effects of 6-acetylacteoside on ovariectomy-induced osteoporosis mice.
    Liu J; Ding S; Yang L; Zhao X; Ren R; Wang Y; Su C; Chen J; Ma X
    Phytomedicine; 2022 Nov; 106():154399. PubMed ID: 36057143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hederagenin protects mice against ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis and bone resorption.
    Tian K; Su Y; Ding J; Wang D; Zhan Y; Li Y; Liang J; Lin X; Song F; Wang Z; Xu J; Liu Q; Zhao J
    Life Sci; 2020 Mar; 244():117336. PubMed ID: 31972206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined treatment with Dendrobium candidum and black tea extract promotes osteoprotective activity in ovariectomized estrogen deficient rats and osteoclast formation.
    Wang MY; Shen C; An MF; Xie CQ; Wu X; Zhu QQ; Sun B; Huang YP; Zhao YL; Wang XJ; Sheng J
    Life Sci; 2018 May; 200():31-41. PubMed ID: 29544757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
    Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.
    Xu Q; Zhan P; Li X; Mo F; Xu H; Liu Y; Lai Q; Zhang B; Dai M; Liu X
    J Cell Mol Med; 2021 Nov; 25(21):10126-10139. PubMed ID: 34651433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway.
    Li Y; Zhuang Q; Tao L; Zheng K; Chen S; Yang Y; Feng C; Wang Z; Shi H; Shi J; Fang Y; Xiao L; Geng D; Wang Z
    Cell Prolif; 2022 Oct; 55(10):e13291. PubMed ID: 35708050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats.
    Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G
    J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-osteoporotic effects of alisol C 23-acetate via osteoclastogenesis inhibition.
    Jia X; Zhu H; Li G; Lan M; Li X; Huang M; Xu W; Wu S
    Biomed Pharmacother; 2021 May; 137():111321. PubMed ID: 33524783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 4'-Demethylnobiletin and 4'-Demethyltangeretin on Osteoclast Differentiation In Vitro and in a Mouse Model of Estrogen-Deficient Bone Resorption.
    Hirata M; Tominari T; Ichimaru R; Takiguchi N; Tanaka Y; Takatoya M; Arai D; Yoshinouchi S; Miyaura C; Matsumoto C; Ma S; Suzuki K; Grundler FMW; Inada M
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
    Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
    Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.